肿瘤影像学
腫瘤影像學
종류영상학
Oncoradiology
2014年
1期
14-18
,共5页
蒋津津%徐俊彦%许晓平%杨忠毅%张建岗%陆晓聆%章英剑
蔣津津%徐俊彥%許曉平%楊忠毅%張建崗%陸曉聆%章英劍
장진진%서준언%허효평%양충의%장건강%륙효령%장영검
99mTc-HYNIC-TOC显像%神经内分泌肿瘤%肝转移
99mTc-HYNIC-TOC顯像%神經內分泌腫瘤%肝轉移
99mTc-HYNIC-TOC현상%신경내분비종류%간전이
99mTc-hydrazinonicotinamide-Tyr3-octreotide imaging%Neuroendocrine tumor%Liver metastases
目的:探讨99mTc-HYNIC-TOC显像探测神经内分泌肿瘤肝(NET)转移灶的价值。方法对17例行99mTc-HYNIC-TOC检查的NET肝转移患者进行回顾性分析,其原发灶为直肠NET者13例、胰腺NET者3例、腹腔来源NET者1例。静脉注射10~15 mCi 99mTc-HYNIC-TOC后2 h行全身和腹部SPECT/CT断层显像,对各肝脏转移灶进行图像分析,测量靶/非靶放射性计数比值(T/NT)。结果99mTc-HYNIC-TOC对NET患者肝转移的诊断阳性率为76.5%(13/17),阳性病灶T/NT比值平均为3.73±2.57(1.50~13.03,n=46),病灶检出率为92.0%(46/50),同机低剂量CT和同期增强诊断CT病灶检出率分别为40.0%(20/50)和64.7%(11/17)。99mTc-HYNIC-TOC SPECT/CT检出最小病灶最大径仅7 mm,T/NT值达2.68。此外,全身平面显像配合SPECT/CT断层显像可更准确发现更多肝内转移灶,对肝转移灶疗效评价也有较好的应用价值。结论99mTc-HYNIC-TOC SPECT/CT显像可准确、灵敏地探测肝转移灶。
目的:探討99mTc-HYNIC-TOC顯像探測神經內分泌腫瘤肝(NET)轉移竈的價值。方法對17例行99mTc-HYNIC-TOC檢查的NET肝轉移患者進行迴顧性分析,其原髮竈為直腸NET者13例、胰腺NET者3例、腹腔來源NET者1例。靜脈註射10~15 mCi 99mTc-HYNIC-TOC後2 h行全身和腹部SPECT/CT斷層顯像,對各肝髒轉移竈進行圖像分析,測量靶/非靶放射性計數比值(T/NT)。結果99mTc-HYNIC-TOC對NET患者肝轉移的診斷暘性率為76.5%(13/17),暘性病竈T/NT比值平均為3.73±2.57(1.50~13.03,n=46),病竈檢齣率為92.0%(46/50),同機低劑量CT和同期增彊診斷CT病竈檢齣率分彆為40.0%(20/50)和64.7%(11/17)。99mTc-HYNIC-TOC SPECT/CT檢齣最小病竈最大徑僅7 mm,T/NT值達2.68。此外,全身平麵顯像配閤SPECT/CT斷層顯像可更準確髮現更多肝內轉移竈,對肝轉移竈療效評價也有較好的應用價值。結論99mTc-HYNIC-TOC SPECT/CT顯像可準確、靈敏地探測肝轉移竈。
목적:탐토99mTc-HYNIC-TOC현상탐측신경내분비종류간(NET)전이조적개치。방법대17례행99mTc-HYNIC-TOC검사적NET간전이환자진행회고성분석,기원발조위직장NET자13례、이선NET자3례、복강래원NET자1례。정맥주사10~15 mCi 99mTc-HYNIC-TOC후2 h행전신화복부SPECT/CT단층현상,대각간장전이조진행도상분석,측량파/비파방사성계수비치(T/NT)。결과99mTc-HYNIC-TOC대NET환자간전이적진단양성솔위76.5%(13/17),양성병조T/NT비치평균위3.73±2.57(1.50~13.03,n=46),병조검출솔위92.0%(46/50),동궤저제량CT화동기증강진단CT병조검출솔분별위40.0%(20/50)화64.7%(11/17)。99mTc-HYNIC-TOC SPECT/CT검출최소병조최대경부7 mm,T/NT치체2.68。차외,전신평면현상배합SPECT/CT단층현상가경준학발현경다간내전이조,대간전이조료효평개야유교호적응용개치。결론99mTc-HYNIC-TOC SPECT/CT현상가준학、령민지탐측간전이조。
Objective To evaluate the value of 99mTc-hydrazinonicotinamide-Tyr3-octreotide (99mTc-HYNIC-TOC) in detection of liver metastases in patients with neuroendocrine tumors. Methods 99mTc-HYNIC-TOC imaging data of 17 neuroendocrine tumor patients with liver metastases were analyzed retrospectively, including 13 rectal, 3 pancreatic and 1 abdominal neuroendocrine tumors. Total body imaging and SPECT/CT imaging were obtained 2 h after intravenous injection of 10-15 mCi 99mTc-HYNIC-TOC. Results 76.5% (13/17) of neuroendocrine tumor patients with liver metastases were positive on 99mTc-HYNIC-TOC imaging. The average target/non-target (T/NT) value of positive lesions was 3.73±2.57 (1.50~13.03, n=46). The detection rate for all the lesions was 92.0% (46/50). The detection rates of TOC imaging with low-dose CT and normal-dose CT were 40.0%(20/50) and 64.7%(11/17) respectively. The size of the smallest lesion detected was only 7 mm, with T/NT value of 2.68. Besides, SPECT/CT scan could provide more correct information than planar imaging. Conclusion 99mTc-HYNIC-TOC SPECT/CT is an excellent method for detection of liver metastases in the patients with neuroendocrine tumors.